Skip to content

Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery

CompletedNot applicableNCT05185752
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The present study compares the Erector Spinae Plane (ESP) block, Pectoral (PECS II) block, and Serratus-Intercostal Fascial Plane (SIFP) block. This is the first article to compare these three locoregional nerve block techniques in acute and chronic postoperative pain in breast tumour surgery. From June 1, 2018, to June 30, 2019, 103 patients undergoing breast cancer surgery were randomised to undergo one of three locoregional techniques (35 for ESP block, 34 for PECS II block, 34 for SIFP block). Locoregional techniques were performed under light sedation and then, general anaesthesia was used for the breast cancer surgery. Outcomes measured included pain (visual analog scale \[VAS\] in immediate postoperatory and at 24 hours. It also was collected opioid use at 24 hours, adverse events, and length of stay (for acute postoperatory). Moreover, at 3 months, a telephone interview was conducted with the patient and VAS was questioned. A year later, the patient was questioned again and asked for VAS, location of her pain, and pharmacological treatment. It was collected if patients were assisted or not by a Pain Unit.

Study details

Official title
Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery
Conditions
Interventions
  • Procedure: SIFP Block Locoregional Interfascial Anesthesic Technique
  • Procedure: PECS II block: Locoregional Interfascial Anesthesic Technique
  • Procedure: ESP block: Locoregional Interfascial Anesthesic Technique
Sponsor
University of Valencia
Start date
2018-06-01
Primary completion
2019-06-30
Sex
Female
Results posted
No results posted in this snapshot
Countries
Spain
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female patient undergoing elective surgery for breast tumour pathology. Exclusion Criteria: * Previous breast tumour pathology surgery. * Breast prosthesis carrier. * Coagulopathy. * Pregnancy or lactation. * Puncture site infection. * Chest wall deformity. * Hemodynamically unstable patient. * Refusal of the patient to undergo locoregional technique. * The patient refuses to take part in the study or revocation of the Informed Consent.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05185752